Krystal Biotech to Report Third Quarter 2026 Financial Results on November 2, 2026
Globe Newswire•22/10/2026•08:00 ET
0
Key Highlights
- ➤Krystal Biotech (KRYS) will report third-quarter 2026 results November 2 before U.S. markets open
- ➤Management will host an 8:30 a.m. ET conference call and webcast November 2
- ➤VYJUVEK is approved in the United States, Europe, and Japan for dystrophic epidermolysis bullosa
PITTSBURGH, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that it will report its third quarter 2026 financial results on Monday, November 2, 2026, prior to the open of U.S. markets.
The Company’s management will also host a conference call and webcast at 8:30 am ET on Monday, November 2, 2026, to discuss the financial results and provide a business update.
Get started
Create a free account to read the full story.